number of access : ?
number of downloads : ?
ID 114810
Author
Shimizu, E Eto Hospital
Takehisa, Y Eto Hospital
Bando, Hiroshi Eto Hospital|Tokushima University|Japan Low Carbohydrate Diet Promotion Association KAKEN Search Researchers
Fujita, M Eto Hospital
Kusaka, Y Eto Hospital
Yuu, M Eto Hospital
Keywords
Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor
Ipragliflozin L-Proline
Depression
Oral Hypoglycemic Agents (OHA)
Low-Carbohydrate Diet (LCD)
Content Type
Journal Article
Description
The case was a 55-year-old female patient with depression for 5 years and type 2 diabetes mellitus (T2DM) for 3 years. She has received anti-depressant and anti-hyperglycemic agents (OHAs). Approximately 1 year ago, her diabetic control became exacerbated without specific triggers. She was started to given Ipragliflozin L-Proline as Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitor. After that, her glucose variability and depression had been improved. According to the previous reports, SGLT-2 inhibitors seem to have anti-depression efficacy for diabetes. The case has been followed up in detail, and this report is expected to be a useful reference for diabetes care.
Journal Title
Diabetes Research : Open Access
Publisher
Asploro
Volume
2
Issue
S1
Start Page
26
End Page
32
Published Date
2020-04-14
Rights
© 2020 Shimizu E, Takehisa Y, Bando H, Fujita M, Kusaka Y, Yuu M. This is an open-access article distributed under the Creative Commons Attribution License(https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI (Published Version)
URL ( Publisher's Version )
FullText File
language
eng
TextVersion
Publisher
departments
Medical Sciences